Prevalence and Detection of Genotyping of Hepatitis C Virus in Hemodialysis Patients
Article Sidebar
Main Article Content
Abstract
Background: Hepatitis C virus is a significant global health distress, affecting millions of individuals worldwide. HCV is a disease that spreads through blood and mostly affects the liver. The condition may resolve on its own or progress to cirrhosis, fibrosis, or liver cancer. Chronic kidney disease patients on hemodialysis are at an increased risk for acquiring HCV infection due to cross contamination in dialysis units, blood transfusion, and kidney transplant. The aims of the study were to determine the genotypes among patients of HCV undergoing hemodialysis.
Objective: The objective of the study was to assess the prevalence and types of HCV genotypes in hemodialysis patients.
Methods: In this cross-sectional study, the HCV positive patients undergoing hemodialysis were enrolled. Samples were collected from the dialysis unit of Farooq Hospital Lahore. RT-PCR was performed to determine the HCV genotypes. This study was conducted on patients of both genders and all age groups. Chi-square test was performed to assess any significant correlation between HCV genotypes in all age groups and both genders.
Results: In this study out of a total of 80 hemodialysis patients, 19 (23.8%) were females and 61 (76.3%) were males. The most common genotype observed was 3 (72.5%) followed by 1a (12.5%), 1(10.0%) and 1b (5.0%).
Conclusion: The current study revealed that the genotype 3 of HCV as the most frequent genotypes in the hemodialysis patients of our population with most patients in the age group of <60 years.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Kaplan DE. Hepatitis C virus. Annals of internal medicine. 2020;173(5):ITC33-ITC48.
Irekeola AA, Malek NA, Wada Y, Mustaffa N, Muhamad NI, Shueb RH. Prevalence of HCV genotypes and subtypes in Southeast Asia: A systematic review and meta-analysis. Plos one. 2021;16(5):e0251673.
Guntipalli P, Pakala R, Kumari Gara S, Ahmed F, Bhatnagar A, Endaya Coronel M. Worldwide prevalence, genotype distribution and management of hepatitis C. Acta gastroenterol belg. 2021;84(4):637-56.
Haqqi A, Munir R, Khalid M, Khurram M, Zaid M, Ali M, et al. Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral immunology. 2019;32(9):402-13.
Petruzziello A, Loquercio G, Sabatino R, Balaban DV, Ullah Khan N, Piccirillo M, et al. Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review. Journal of clinical laboratory analysis. 2019;33(5):e22876.
Wang X, Fan X, Deng H, Zhang X, Zhang K, Li N, et al. Efficacy and safety of glecaprevir/pibrentasvir for chronic hepatitis C virus genotypes 1–6 infection: A systematic review and meta-analysis. International journal of antimicrobial agents. 2019;54(6):780-9.
Khan MU, Mahmoud MI, Butt AA. Hepatitis c virus and chronic kidney disease. Expert Review of Gastroenterology & Hepatology. 2020;14(7):579-90.
Yousif MA, Mohammed IS, Mohammed SO, Gebreel ME, Alhaj RM, Alsier DA, et al. Nosocomial Transmission of Hepatitis B Surface Antigen and Anti-Hepatitis C Virus among Hemodialysis Patients. Archives of Pharmacy Practice¦ Volume. 2022;13(3).
de Jesus Rodrigues de Freitas M, Fecury AA, de Almeida MKC, Freitas AS, de Souza Guimarães V, da Silva AM, et al. Prevalence of hepatitis C virus infection and genotypes in patient with chronic kidney disease undergoing hemodialysis. Journal of medical virology. 2013;85(10):1741-5.
Porrett PM, Reese PP, Holzmayer V, Coller KE, Kuhns M, Van Deerlin VM, et al. Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ. American Journal of Transplantation. 2019;19(9):2525-32.
Karim F, Nasar A, Alam I, Alam I, Hassam S, Gul R, et al. Incidence of active HCV infection amongst blood donors of Mardan District, Pakistan. Asian Pac J Cancer Prev. 2016;17(1):235-8.
Anwar F, Tayyab M, Haq I, Shah OU. Viral overload of COVID-19 pandemics: Overweight people a soft target to get an infection. International Journal of Clinical Virology. 2021;5(2):070-1.
Rehman A, Haq I, Asghar M, Afridi G, Faisal S. Sero-epidemiological Identification of Dengue Virus in Individuals at District Shangla, Khyber Pakhtunkhwa. Pakistan J Biomedical Sci. 2020;9(3):10.
Jan Z, Khan MS, Ahmad SU, Saadia H, Ullah I, Said A, et al. Evaluation of Cyclin-Dependent Kinase Inhibitor Signalling network in esophageal Adenocarcinoma Via computational and statistical approaches. Bioscience Research. 2021;18(3):2022-9.
Chopra H, Bibi S, Mishra AK, Tirth V, Yerramsetty SV, Murali SV, et al. Nanomaterials: a promising therapeutic approach for cardiovascular diseases. Journal of Nanomaterials. 2022;2022:1-25.
Haq I, Muhammad A, Fazli Zahir MK, Anwar F, Akhtar MS, Ullah F. Serological and Epidemiology study of Helicobacter pylori infection among Dyspeptic patients in District Peshawar Pakistan. Adv Biores. 2020;11(3):81-5.
Joukar F, Besharati S, Mirpour H, Mansour-Ghanaei F. Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepatitis monthly. 2011;11(3):178.
Hussein NR, Taher AM. The seroprevalence of HBV and HCV Infection in newly recruited police in Duhok city, Kurdistan Region, Iraq. Int J Sci Basic Appl Res. 2015;24(1):112-6.
Jadoul M, Bieber BA, Martin P, Akiba T, Nwankwo C, Arduino JM, et al. Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients. Kidney international. 2019;95(4):939-47.
Ghorbani NR, Djalalinia S, Modirian M, Abdar ZE, Mansourian M, Gorabi AM, et al. Prevalence of hepatitis C infection in Iranian hemodialysis patients: an updated systematic review and meta-analysis. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2017;22.
Hussein NR, Saleema ZS, Abd QH. Direct acting antiviral treatment for patients with end-stage kidney disease with acute HCV infection. Mediterranean journal of hematology and infectious diseases. 2019;11(1).
Hussein N, Tunjel I, Basharat Z, Taha A, Irving W. The treatment of HCV in patients with haemoglobinopathy in Kurdistan Region, Iraq: a single centre experience. Epidemiology & Infection. 2016;144(8):1634-40.
Ahmad W, Ijaz B, Javed FT, Jahan S, Shahid I, Khan FM, et al. HCV genotype distribution and possible transmission risks in Lahore, Pakistan. World Journal of Gastroenterology. 2010;16(34):4321-8.
Ali M, Kanwal L, Tassaduqe K, Iqbal R. Prevalence of Hepatitis C Virus (HCV) in Relation to Its Promotive Factors Among Human Urban Population of Multan, Pakistan. European Journal of General Medicine. 2009;6(2).
Qamar Z, Anwar F, Ahmad R, Haq I, Khan AMK, Hussain R, et al. Prevalence of Hepatitis C virus and determination of its genotypes in subjects of Tehsil Daggar District Buner, KP, Pakistan. Clinical Epidemiology and Global Health. 2021;12:100809.